建立一家研究药房以支持利比里亚的埃博拉临床研究。
Establishment of a research pharmacy to support Ebola clinical research in Liberia.
作者信息
Pierson Jerome F, Kirchoff Matthew Carl, Tyee Rev Tijli, Montello Michael J, Rhie Julie K
出版信息
J Am Pharm Assoc (2003). 2017 Jul-Aug;57(4):542-546. doi: 10.1016/j.japh.2017.04.002. Epub 2017 Jun 10.
OBJECTIVE
This article describes the establishment of a research pharmacy to support the Partnership for Research on Ebola Vaccines in Liberia (PREVAIL) vaccine study for Ebola virus disease.
SETTING
This article describes the establishment of the pharmacy element to support the overall research program during an Ebola outbreak in Monrovia, Liberia, in 2014 and 2015.
PRACTICE INNOVATION
The need for the rapid establishment of infrastructure to support the Liberia-United States joint clinical research partnership in response to the emerging Ebola virus disease provided the opportunity for collaboration among Liberian and U.S. pharmacists.
PRACTICE DESCRIPTION
Resource austere and research naïve.
EVALUATION
Research pharmacy prepared and randomized 1500 vaccinations in support of PREVAIL.
RESULTS
Experiences of the Liberian and U.S. pharmacists involved in the program are described.
CONCLUSION
The partnership was successful in the conduct of the study. More importantly, the capacity for Liberian pharmacists to support clinical research was established. In addition, the U.S. team learned several important lessons that will help prepare them for responding to research needs in future infectious disease outbreaks.
目的
本文描述了为支持利比里亚埃博拉疫苗研究合作项目（PREVAIL）的埃博拉病毒病疫苗研究而设立的一家研究药房。
背景
本文描述了在2014年和2015年利比里亚蒙罗维亚埃博拉疫情期间，为支持整体研究项目而设立药房部门的情况。
实践创新
为应对新出现的埃博拉病毒病，需要迅速建立基础设施以支持利比里亚-美国联合临床研究合作关系，这为利比里亚和美国药剂师之间的合作提供了契机。
实践描述
资源匮乏且缺乏研究经验。
评估
研究药房准备并随机分配了1500次疫苗接种，以支持PREVAIL项目。
结果
描述了参与该项目的利比里亚和美国药剂师的经历。
结论
该合作在研究开展方面取得了成功。更重要的是，确立了利比里亚药剂师支持临床研究的能力。此外，美国团队吸取了若干重要经验教训，这将有助于他们为应对未来传染病疫情中的研究需求做好准备。
Zotero 插件